• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor

    7/4/24 3:18:13 PM ET
    $MRNA
    $NVDA
    $TSLA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Semiconductors
    Technology
    Get the next $MRNA alert in real time by email

    Signs are emerging that the market boom surrounding artificial intelligence (AI) might be taking on the characteristics of a bubble.

    This warning comes from Wall Street veteran investor Ed Yardeni, President of Yardeni Research, Inc., in a note to clients on July 4.

    “While we love the productivity-enhancing possibilities that AI offers, the AI phenomenon has many of the hallmarks of an inflating bubble,” Yardeni cautioned.

    He noted that there are “big bucks chasing the AI dream,” with substantial funds directed toward companies leveraging AI technology.

    ‘Too Much Capital Can End Even The Best Of Parties’

    This year alone, Yardeni Research highlighted several advancements AI can achieve:

    • Nvidia Corp. (NASDAQ:NVDA) recently introduced Omniverse Cloud Sensor RTX, new AI simulation software to improve safety, reduce costs, and expedite the training of autonomous driving systems.
    • Moderna Inc. (NASDAQ:MRNA) plans to integrate ChatGPT Enterprise across its organization to revolutionize business processes.
    • Couples are now using ChatGPT to plan weddings, bypassing the traditional, costly wedding planner. ChatGPT assists in creating wedding websites, writing vows, and managing budgets.
    • Los Angeles plans to test AI-powered cameras on Metro buses this summer to ticket drivers illegally parked in bus lanes.
    • AI is also aiding teachers in developing lesson plans and grading papers.

    “But at some point, too much capital can end even the best of parties,” Yardeni remarked, signaling the potential pitfalls of overinvestment.

    Yardeni pointed out that hundreds of small companies have raised billions from venture capitalists eager to find the next ChatGPT.

    In the past three years, $330 billion has been invested in 26,000 AI startups, a 66% increase from the $200 billion spent on 20,350 startups from 2018-2020.

    Last year, generative AI deals attracted $21.8 billion, a fivefold increase from 2022.

    Expectations Running Wild

    “Many AI newcomers have yet to turn a profit,” Yardeni warned, suggesting that the AI-driven rally has largely been fueled by profit expectations rather than current earnings.

    The semiconductor industry, which saw only 0.2% earnings growth in 2023, is projected to grow earnings by 47.5% this year and 38.8% in 2025, according to Yardeni’s latest estimates.

    Several companies are running out of funds, including Stability AI. The startup reportedly laid off employees and recently saw its CEO depart.

    “Fortunately, most of these companies haven't borrowed debt in the capital markets, so a repeat of the telecom bust is unlikely,” Yardeni noted.

    However, if AI startups run out of cash, their suppliers could see AI-related revenues dry up quickly, generating a domino effect on the overall industry.

    The Rockstar Factor

    “We're the first to agree that widespread adoption of AI will be a game-changer for many industries,” Yardeni stated.

    “But tech CEOs are making some pretty wild claims. Is the potential of AI really all they're cracking it up to be?”

    Yardeni highlighted that AI has its “rockstars,” including Nvidia's Jensen Huang, ChatGPT's Sam Altman, and Tesla Inc. (NASDAQ:TSLA)'s Elon Musk.

    He recalled how ChatGPT CEO Sam Altman compared AI to the discovery of agriculture and the industrial revolution. Yardeni predicts that AI will significantly boost productivity and help global GDP grow 7% annually, doubling within a decade.

    Indeed, AI will enhance productivity and economic growth. But Yardeni questions the feasibility of doubling the world’s economy in such a short time.

    “Doubling the size of the world economy in a decade is quite a claim,” Yardeni stated.

    Read now:

    • OpenAI’s ChatGPT macOS App Had A Major Security Flaw: Conversations Were Stored In Plain Text
    Get the next $MRNA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MRNA
    $NVDA
    $TSLA

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    NVIDIA Corporation
    $NVDA
    1/15/2026$240.00Outperform
    RBC Capital Mkts
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    Moderna Inc.
    $MRNA
    1/7/2026$34.00Neutral
    UBS
    Tesla Inc.
    $TSLA
    1/2/2026$444.00 → $439.00Hold
    Truist
    More analyst ratings

    $MRNA
    $NVDA
    $TSLA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Tesla with a new price target

    BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00

    3/4/26 8:40:18 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $MRNA
    $NVDA
    $TSLA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon bought $999,959,042 worth of shares (2,568,732 units at $389.28) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    9/15/25 6:01:19 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Director Gebbia Joseph bought $1,025,232 worth of shares (4,000 units at $256.31) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/28/25 6:45:17 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Chief Executive Officer Bancel Stephane bought $5,004,318 worth of shares (160,314 units at $31.22) (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    3/4/25 4:27:16 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $MRNA
    $NVDA
    $TSLA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Zhu Xiaotong

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/2/26 8:08:52 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Wilson-Thompson Kathleen

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/1/26 7:00:13 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Stevens Mark A

    4 - NVIDIA CORP (0001045810) (Issuer)

    3/24/26 5:13:39 PM ET
    $NVDA
    Semiconductors
    Technology

    $MRNA
    $NVDA
    $TSLA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tesla First Quarter 2026 Production, Deliveries & Deployments

    In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026   Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin

    4/2/26 9:03:00 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    NVIDIA AI Ecosystem Expands as Marvell Joins Forces Through NVLink Fusion

    SANTA CLARA, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- NVIDIA and Marvell Technology, Inc. (NASDAQ:MRVL) today announced a strategic partnership to connect Marvell to the NVIDIA AI factory and AI-RAN ecosystem through NVIDIA NVLink Fusion™, offering customers building on NVIDIA architectures greater choice and flexibility in developing next-generation infrastructure. The companies will also collaborate on silicon photonics technology. In addition, NVIDIA has invested $2 billion in Marvell. The partnership builds on NVIDIA NVLink Fusion, a rack-scale platform that enables customers to develop semi-custom AI infrastructure using the NVIDIA NVLink™ ecosystem. Marvell will provide custom XP

    3/31/26 8:00:00 AM ET
    $MRVL
    $NVDA
    Semiconductors
    Technology

    BetterInvesting™ Magazine Update on NVIDIA Corp. (NASDAQ: NVDA) and Tennant Company (NYSE: TNC)

    TROY, Mich., March 27, 2026 /PRNewswire/ -- NVIDIA Corp.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers NVIDIA Corp. (NASDAQ:NVDA) as worthy of further study and has named the company its "Stock to Study" for the June/July 2026 issue for investors' informational and educational use. The fundamental data is eye-opening; investors can view NVIDIA's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/trial/ssgplus/?tic

    3/27/26 4:15:00 PM ET
    $NVDA
    $TNC
    Semiconductors
    Technology
    Industrial Machinery/Components
    Industrials

    $MRNA
    $NVDA
    $TSLA
    SEC Filings

    View All

    Tesla Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Tesla, Inc. (0001318605) (Filer)

    4/2/26 9:07:13 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Tesla Inc.

    SCHEDULE 13G/A - Tesla, Inc. (0001318605) (Subject)

    3/27/26 1:36:06 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Moderna Inc.

    SCHEDULE 13G/A - Moderna, Inc. (0001682852) (Subject)

    3/27/26 10:51:07 AM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $MRNA
    $NVDA
    $TSLA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $MRNA
    $NVDA
    $TSLA
    Financials

    Live finance-specific insights

    View All

    Tesla First Quarter 2026 Production, Deliveries & Deployments

    In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026   Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin

    4/2/26 9:03:00 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2026

    Record quarterly revenue of $68.1 billion, up 20% from Q3 and up 73% from a year agoRecord quarterly Data Center revenue of $62.3 billion, up 22% from Q3 and up 75% from a year agoRecord full-year revenue of $215.9 billion, up 65% SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported record revenue for the fourth quarter ended January 25, 2026, of $68.1 billion, up 20% from the previous quarter and up 73% from a year ago. For fiscal 2026, revenue was $215.9 billion, up 65% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 75.0% and 75.2%, respectively. For fiscal 2026, GAAP and non-GAAP gross margins were 71.1% and

    2/25/26 4:31:17 PM ET
    $NVDA
    Semiconductors
    Technology

    NVIDIA Sets Conference Call for Fourth-Quarter Financial Results

    SANTA CLARA, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- NVIDIA will host a conference call on Wednesday, February 25, at 2 p.m. PT (5 p.m. ET) to discuss its financial results for the fourth quarter and fiscal year 2026, which ended January 25, 2026. The call will be webcast live (in listen-only mode) on investor.nvidia.com. The company's prepared remarks will be followed by a Q&A session, which will be limited to questions from financial analysts and institutional investors. Ahead of the call, NVIDIA will provide written commentary on its fourth-quarter results from Colette Kress, the company's executive vice president and chief financial officer. This material will be posted to investor

    1/28/26 5:00:00 PM ET
    $NVDA
    Semiconductors
    Technology

    $MRNA
    $NVDA
    $TSLA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by NVIDIA Corporation

    SC 13G/A - NVIDIA CORP (0001045810) (Subject)

    11/12/24 10:32:12 AM ET
    $NVDA
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by Moderna Inc. (Amendment)

    SC 13G/A - Moderna, Inc. (0001682852) (Subject)

    4/10/24 2:03:52 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Tesla Inc. (Amendment)

    SC 13G/A - Tesla, Inc. (0001318605) (Subject)

    2/14/24 4:01:18 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $MRNA
    $NVDA
    $TSLA
    Leadership Updates

    Live Leadership Updates

    View All

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Scientists Pointing to Hidden Power Source That Could Reshape Future of AI

    This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement. AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- MiningNewsWire: Global electricity demand is reaching a pivotal turning point. The International Energy Agency (IEA) now projects that global data-center electricity use will almost double by 2030, with AI-focused facilities increasing their consumption more than four times over the same span — a trajectory pushing power grids in the United States, China, Europe, Southeast Asia and other regions to their limits. The bottleneck is no longer data throughput or semiconductor performance; the critical constraint has become electricity it

    12/3/25 8:30:00 AM ET
    $AMZN
    $AVGO
    $META
    Catalog/Specialty Distribution
    Consumer Discretionary
    Semiconductors
    Technology

    Palantir and NVIDIA Team Up to Operationalize AI — Turning Enterprise Data Into Dynamic Decision Intelligence

    News Summary Palantir is integrating NVIDIA accelerated computing, NVIDIA CUDA-X libraries and open-source NVIDIA Nemotron models into its Ontology framework at the core of the Palantir AI Platform.Lowe's is pioneering operational AI for its supply chain logistics with Palantir and NVIDIA. WASHINGTON, Oct. 28, 2025 (GLOBE NEWSWIRE) -- GTC Washington, D.C. -- NVIDIA today announced a collaboration with Palantir Technologies Inc. to build a first-of-its-kind integrated technology stack for operational AI — including analytics capabilities, reference workflows, automation features and customizable, specialized AI agents — to accelerate and optimize complex enterprise and government systems.

    10/28/25 1:36:17 PM ET
    $NVDA
    Semiconductors
    Technology